{"id":533691,"date":"2021-09-02T07:33:12","date_gmt":"2021-09-02T11:33:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/"},"modified":"2021-09-02T07:33:12","modified_gmt":"2021-09-02T11:33:12","slug":"kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/","title":{"rendered":"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">LEXINGTON, Mass., Sept.  02, 2021  (GLOBE NEWSWIRE) &#8212; Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that CEO Dan Menichella will participate in a fireside chat at the Morgan Stanley 19<sup>th<\/sup> Annual Virtual Global Healthcare Conference at 2:45PM ET on Thursday, September 9.<\/p>\n<p>The webcast of the presentation will be made available in the Investors &amp; Media section of Kaleido\u2019s website at\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-Lv4P-jCrmQH6zBLAEx43U4WMp7g9ncH9pggu0l3N0oC9-73n3uwkFguRMPC8uFWKaq_orHDqWOB8tUNpowLLlxNNy1K8hlWS8MlaOzjX6coHROCYewFBawuYeAbhDbuFrbURZq7qJuYi_kw63S7Jylh8UW4UCchihD2L07Oeug=\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/investors.kaleido.com\/events-presentations<\/a><\/u>. An archived replay will be available for 90 days following the event.<\/p>\n<p>\n        <strong>About Kaleido Biosciences<\/strong><br \/>\n        <br \/>Kaleido Biosciences\u00a0is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company has built a proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT\u2122).\u00a0MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the gut\u2019s existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs. To learn more, visit\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-Lv4P-jCrmQH6zBLAEx43auiDavmHh9kefZoIhIPeNVH71jnIFt_v2iywQLcgzXozDM_36SLCIegi92nPAbmkQ==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/kaleido.com\/<\/a><\/u>.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong><br \/>\n          <u>Kaleido Biosciences<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>William Duke, Jr.<br \/>Chief Financial Officer<br \/>617-890-5772<br \/><u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Ji-7aqygh839XMNWHE_e4ZIqutNez2yTT2lboY40f_nwgAKXPT9RwjwRQXWEbXklE4voGLLRpeRRgt-3Cng3ajuSS6vrsu5f6c5EHCLuFbQ=\" rel=\"nofollow noopener\" target=\"_blank\">william.duke@kaleido.com<\/a><\/u><\/p>\n<p>\n        <strong><br \/>\n          <u>Investors and Media<\/u><br \/>\n        <\/strong><br \/>\n        <br \/>Kotaro Yoshida<br \/>Argot Partners<br \/>212-600-1902<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rXFMVESJozz6Xmch-LYF-Di-MkDURYJ6qZ9Xs5x1ywYOCp1Xd1mZ1KYJUSx7AQRyjgW0YzHsftBKYRgxcPTctdy2tXx7hoJUuhwPRQQPrH8=\" rel=\"nofollow noopener\" target=\"_blank\">kaleido@argotpartners.com<\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OWZiZmM3M2QtN2NhNC00YTRhLWEyOGEtYmUyOTQ2MWEzZjFiLTExMzU4Mzg=\/tiny\/Kaleido-Biosciences.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>LEXINGTON, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that CEO Dan Menichella will participate in a fireside chat at the Morgan Stanley 19th Annual Virtual Global Healthcare Conference at 2:45PM ET on Thursday, September 9. The webcast of the presentation will be made available in the Investors &amp; Media section of Kaleido\u2019s website at\u00a0https:\/\/investors.kaleido.com\/events-presentations. An archived replay will be available for 90 days following the event. About Kaleido Biosciences Kaleido Biosciences\u00a0is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-533691","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"LEXINGTON, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that CEO Dan Menichella will participate in a fireside chat at the Morgan Stanley 19th Annual Virtual Global Healthcare Conference at 2:45PM ET on Thursday, September 9. The webcast of the presentation will be made available in the Investors &amp; Media section of Kaleido\u2019s website at\u00a0https:\/\/investors.kaleido.com\/events-presentations. An archived replay will be available for 90 days following the event. About Kaleido Biosciences Kaleido Biosciences\u00a0is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company &hellip; Continue reading &quot;Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-02T11:33:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference\",\"datePublished\":\"2021-09-02T11:33:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/\"},\"wordCount\":241,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/\",\"name\":\"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc=\",\"datePublished\":\"2021-09-02T11:33:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference - Market Newsdesk","og_description":"LEXINGTON, Mass., Sept. 02, 2021 (GLOBE NEWSWIRE) &#8212; Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that CEO Dan Menichella will participate in a fireside chat at the Morgan Stanley 19th Annual Virtual Global Healthcare Conference at 2:45PM ET on Thursday, September 9. The webcast of the presentation will be made available in the Investors &amp; Media section of Kaleido\u2019s website at\u00a0https:\/\/investors.kaleido.com\/events-presentations. An archived replay will be available for 90 days following the event. About Kaleido Biosciences Kaleido Biosciences\u00a0is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health. The Company &hellip; Continue reading \"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-02T11:33:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference","datePublished":"2021-09-02T11:33:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/"},"wordCount":241,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/","name":"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc=","datePublished":"2021-09-02T11:33:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNjI5NyM0Mzc4Mjk0IzIxMjQyNjc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kaleido-biosciences-to-participate-in-the-morgan-stanley-19th-annual-virtual-global-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533691","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=533691"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/533691\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=533691"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=533691"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=533691"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}